CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-12 | AZAB MOHAMMAD Director | Option exercise · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2022-11-25 | PATOU GARY Director | Option exercise | +2,057 | $2.68 | $6K | 25,630 |
| 2022-11-25 | PATOU GARY Director | Shares withheld for taxes | −120 | $34.37 | $4K | 25,510 |
| 2022-11-25 | PATOU GARY Director | Sale | −1,937 | $34.79 | $67K | 23,573 |
| 2022-11-25 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2022-11-23 | PATOU GARY Director | Sale | −2,057 | $34.33 | $71K | 23,573 |
| 2022-11-07 | DiFabio Andrea Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise | +9,000 | $9.44 | $85K | 9,000 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise | +32 | $7.49 | $240 | 9,032 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise | +813 | $8.40 | $7K | 9,845 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise | +2,292 | $3.10 | $7K | 12,137 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise | +6,511 | $4.75 | $31K | 18,648 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Shares withheld for taxes | −3,293 | $39.53 | $130K | 15,355 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Sale | −15,355 | $39.57 | $608K | 0 |
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,000 | 0 | ||
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −32 | 0 | ||
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −813 | 0 | ||
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −2,292 | 0 | ||
| 2022-09-02 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −6,511 | 0 | ||
| 2022-09-01 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Option exercise | +50,000 | $4.75 | $238K | 66,796 |
Page 14 of 16 · 308 trades